Teva Pharmaceutical Industries Ltd

Kestra Advisory Services, LLC TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

46,357

Value ($000)

1,447

Weight

0.0%

2020 Q3 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,447	0.0%	46,357	12/31/2025
2025 Q3	11/14/2025	846	0.0%	41,875	9/30/2025
2025 Q2	8/15/2025	721	0.0%	43,048	6/30/2025
2025 Q1	5/14/2025	591	0.0%	38,478	3/31/2025
2024 Q4	2/10/2025	980	0.0%	44,472	12/31/2024
2024 Q3	11/13/2024	685	0.0%	37,990	9/30/2024
2024 Q2	8/14/2024	638	0.0%	43,984	6/30/2024
2024 Q1	5/15/2024	559	0.0%	39,621	3/31/2024
2023 Q1	5/12/2023	91	0.0%	10,251	3/31/2023
2022 Q4	1/31/2023	186	0.0%	20,366	12/31/2022
2022 Q3	11/1/2022	121	0.0%	14,986	9/30/2022
2022 Q2	8/12/2022	300	0.0%	39,841	6/30/2022
2022 Q1	7/20/2022	97	0.0%	10,331	3/31/2022
2021 Q4	7/25/2022	103	0.0%	12,899	12/31/2021
2021 Q3	7/25/2022	118	0.0%	12,106	9/30/2021
2021 Q2	7/26/2022	105	0.0%	10,599	6/30/2021
2021 Q1	7/27/2022	206	0.0%	17,837	3/31/2021
2020 Q4	7/28/2022	517	0.0%	53,811	12/31/2020
2020 Q3	7/29/2022	327	0.0%	36,210	9/30/2020